We studied 461 KTR from a single-center after median 6.1 years (interquartile range 3.0-11.9) after transplantation. At baseline, vitamin D and K status were measured by 25-hydroxyvitamin D [25(OH)D] and dephosphorylated uncarboxylated matrix gla protein (dp-ucMGP) respectively. Vitamin D and vitamin K were categorized by 25(OH)D <50/50 mmol/L and median dp-ucMGP <996/996 pmol/L. We used Cox regression analyses to estimate hazard ratios (HR) and 95% confidence intervals. RESULTS: At baseline, mean age was 52612 years, and 122 KTR (26%) had combined low vitamin D and K status. During median 9.8 years (interquartile range 8.7-10.3) follow-up, 128 patients (28%) died and 48 (10%) developed graft failure. Combined low vitamin D and K status was associated with 2.46 (95% CI 1.30-4.63) greater risk of all cause-mortality and a 2.93 (95% CI 1.05-8.13) greater risk of graft failure. Of all KTR, 45 (10%) used vitamin D supplements, mainly alfacalcido (80%). Plasma dp-ucMGP was more strongly associated with all-cause mortality and graft failure in vitamin D supplement users compared to no vitamin D supplement users: HR per 500 pmol/L ducMGP 1.11 (1.04-1.19) and 1.41 (1.08-1.84), (see Figure 1 , P-for interaction 0.06 and 0.108, respectively adjusted for age and sex). CONCLUSIONS: Combined low vitamin D and K status is highly prevalent in stable KTR. The joint association of low vitamin D and K status is associated with greater risk of premature mortality. Vitamin D supplement users with low vitamin K status have a strong risk of premature mortality and graft failure compared to non-users. Future studies should address whether combined vitamin D and K supplementation may lead to improved outcomes after kidney transplantation.
INTRODUCTION AND AIMS:
Moderate alcohol consumption is considered to provide cardioprotective effects, but the role of alcohol consumption remains inconclusive in chronic kidney disease. We aimed to evaluate the influences of alcohol consumption on incident chronic kidney disease (CKD) and proteinuria in a cohort of health checkup population. METHODS: This cohort consisted of 7501 adults who were free of CKD at baseline and repeatedly participated in a health check-up program during [2003] [2004] [2005] [2006] [2007] [2008] [2009] . We obtained the participants' demographic data, laboratory examinations, comorbidities, and lifestyle behaviors (including the amount of alcohol consumption, smoking, or exercise). According to the self-reported questionnaire, we classified participants into nondrinkers, occasional drinkers (less than once per week), and frequent drinkers (at least once per week). We used the Chronic Kidney Disease Epidemiology Collaboration equation to calculate the estimated glomerular filtration rate (eGFR). The primary outcome was the decline of eGFR below 60 mL/min/1.73m 2 , and the secondary outcome was incident proteinuria. Multivariate Cox proportional hazards models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for outcomes comparing different levels of alcohol consumption. RESULTS: There were 38% nondrinkers, 50% occasional drinkers, and 11% frequent drinkers. During a mean follow-up time of 3 years, 324 participants had a decline of eGFR below 60 mL/min/1.73m 2 and 718 participants had incident proteinuria. Compared with nondrinkers, occasional drinkers (HR 1.13, 95% CI 0.89-1.45) and frequent drinkers (HR 1.02, 95% CI 0.68-1.52) did not show a lower hazard for decline of eGFR below 60 mL/min/1.73m 2 (Table 1) . Compared with nondrinkers, occasional drinkers (HR 1.02, 95% CI 0.87-1.20) and frequent drinkers (HR 1.28, 95% CI 0.99-1.66) did not show a lower hazard of incident proteinuria (Table 2) .
CONCLUSIONS:
Our analyses showed neutral effects of alcohol consumption on the incidence of abnormal eGFR or proteinuria. In Italy, studies analyzing selected age group populations reported a CKD stages 3-5 prevalence of 5.7-7.5% in men and 6.2-6.5% in women (GUBBIO, CARHES), or 8.5% overall (INCIPE). Yet, real-world data is still lacking. We designed a population study based on administrative data, including the most advanced aged groups, typically under-represented in epidemiological studies.The objectives were: A.To estimate CKD stages 3-5 prevalence in the resident population of a Tuscan city health unit (Azienda Sanitaria Locale, ASL -Empoli), and in diabetic and hypertensive patients; B. To standardize data on the whole regional population. METHODS: All individuals referring to the ASL Empoli were reviewed through the Tuscan health administrative database. Patients >45 years with a serum creatinine (SCr) determination by isotopic dilution mass spectrometry to allow GFR estimation by CKD-EPI equation in 2011-2013 were included and stratified in CKD stages 3a, 3b and 4-5. Renal replacement therapy patients were excluded. Crude and standardized prevalence by sex, age and comorbidity were recorded. RESULTS: Of the 238,873 Empoli residents, 79,277 (78%) were> 45 years and performed at least one SCr determination. Among them, 9082 (11.4%) had GFR <60 ml/ min and 686 (0.87%) had GFR <30 ml/min. Age and sex distribution of CKD 3-5 individuals significantly differed from both the whole study and Empoli populations (p <0.0001). Prevalence in diabetic and hypertensive populations is reported in Tab 1.After standardization, estimated GFR <60 ml/min prevalence in the general population >45 years was 10.5%, distributed as follows: stage 3a 7.1%, stage 3b 2.6%, stage 4-5 0.8 %. As expected, prevalence progressively increased with age till 36.5% for stage 3 and 4.1% for stages 4-5 in >85 years (Fig 1) . 
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